Correlation Between Viracta Therapeutics and OnKure Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and OnKure Therapeutics,, you can compare the effects of market volatilities on Viracta Therapeutics and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and OnKure Therapeutics,.
Diversification Opportunities for Viracta Therapeutics and OnKure Therapeutics,
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Viracta and OnKure is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and OnKure Therapeutics, go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and OnKure Therapeutics,
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the OnKure Therapeutics,. In addition to that, Viracta Therapeutics is 1.49 times more volatile than OnKure Therapeutics,. It trades about -0.31 of its total potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.22 per unit of volatility. If you would invest 1,750 in OnKure Therapeutics, on September 1, 2024 and sell it today you would lose (274.00) from holding OnKure Therapeutics, or give up 15.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. OnKure Therapeutics,
Performance |
| Timeline |
| Viracta Therapeutics |
| OnKure Therapeutics, |
Viracta Therapeutics and OnKure Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and OnKure Therapeutics,
The main advantage of trading using opposite Viracta Therapeutics and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.| Viracta Therapeutics vs. Cue Biopharma | Viracta Therapeutics vs. Tff Pharmaceuticals | Viracta Therapeutics vs. Lantern Pharma | Viracta Therapeutics vs. Eliem Therapeutics |
| OnKure Therapeutics, vs. Trupanion | OnKure Therapeutics, vs. Codexis | OnKure Therapeutics, vs. Hawkins | OnKure Therapeutics, vs. Direct Line Insurance |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |